Five-year overall survival and NRM by cGVHD risk score*
| Risk group . | Overall risk score . | n . | Overall survival (95% CI)† . | NRM (95% CI)‡ . |
|---|---|---|---|---|
| RG1 | 0-2 | 90 | 90.8 (84.6-96.9) | 4.6 (0,2-9.1) |
| RG2 | 3-6 | 1712 | 67.1 (69.4-69.4) | 20.4 (18.5-22.6) |
| RG3 | 7-8 | 627 | 50.5 (46.4-54.6) | 33.2 (29.1-36.8) |
| RG4 | 9-10 | 984 | 40.2 (37.0-43.3) | 43.2 (40.1-46.4) |
| RG5 | 11 | 87 | 21.0 (12.2-29.8) | 63.4 (53.3-73.6) |
| RG6 | > 12 | 50 | 4 (0-9.4) | 72.0 (59.4-84.6) |
| RG5 and RG6 | > 11 | 137 | 14.5 (8.5-20.6) | 66.9 (58.9-74.9) |
| Risk group . | Overall risk score . | n . | Overall survival (95% CI)† . | NRM (95% CI)‡ . |
|---|---|---|---|---|
| RG1 | 0-2 | 90 | 90.8 (84.6-96.9) | 4.6 (0,2-9.1) |
| RG2 | 3-6 | 1712 | 67.1 (69.4-69.4) | 20.4 (18.5-22.6) |
| RG3 | 7-8 | 627 | 50.5 (46.4-54.6) | 33.2 (29.1-36.8) |
| RG4 | 9-10 | 984 | 40.2 (37.0-43.3) | 43.2 (40.1-46.4) |
| RG5 | 11 | 87 | 21.0 (12.2-29.8) | 63.4 (53.3-73.6) |
| RG6 | > 12 | 50 | 4 (0-9.4) | 72.0 (59.4-84.6) |
| RG5 and RG6 | > 11 | 137 | 14.5 (8.5-20.6) | 66.9 (58.9-74.9) |
Shown is the probability of overall survival (95% CI) at 5 years and the cumulative incidence of NRM (95% CI) at 5 years.
P < .01 for all comparisons of overall survival (RG1 vs RG2 vs RG3 vs RG4 vs RG5 vs RG6 and RG4 vs RG5 + 6).
P < .01 for the following comparisons of NRM: RG1 vs RG2 vs RG3 vs RG4 vs RG5. RG5 vs RG6 was not significant (P = 0.2984). For RG4 vs RG5 and RG6, P < .0001.